Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Blog|Articles|August 23, 2023
Pointers With Portela: Skin Care Trivia
Author(s)Dustin Portela, DO
In this week’s Pointers With Portela, the 208SkinDoc asks consumers skin care trivia questions about vitamin C, layers of the skin, keratosis pilaris, and more.
Advertisement
In his most recent YouTube episode,
- What vitamin is often associated with promoting healthy skin and is found in citrus fruits?
- Name the top layer of the skin
- What skin condition is characterized by small bumps that feel like sand paper?
- What does SPF stand for?
- What is the term for darkening of the skin?
Opinions expressed are that of Portela and do not express the views or opinions of Dermatology Times®.
Dr Portela's social media channels:
YouTube:
2.
3.
Instagram:
Twitter:
Advertisement
Related to this article
The FDA clearance allows Edesa to expand an ongoing placebo-controlled study of the CXCL10 antibody EB06 to US sites, with topline data expected in the fourth quarter of 2027.
The novel oral helicase-primase inhibitor demonstrated significantly higher rates of complete lesion healing compared with investigator’s choice treatment in the phase 3 PRIOH-1 trial.
Prospective data suggest DecisionDx-Melanoma may help refine SLNB decisions and identify recurrence risk beyond conventional staging.
Falk G. Bechara, MD, discusses long-term tunnel control, structural damage, and the evolving role of biologics and surgery in HS care.
Galderma has agreed to acquire ZO Skin Health for $1.5 billion, adding the physician-dispensed skincare brand to a portfolio that already includes Cetaphil and Alastin.
New dermatology research explores hidden steroids in OTC products, infant eczema, melanoma prevention, cutaneous lymphoma, and pediatric AD.
SYX-5219 improved disease severity and itch in a Phase 1b trial of adults with moderate to severe atopic dermatitis.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults
2
EADV 2026 Atopic Dermatitis Highlights: Tilrekimig, RAC2 Inhibition, and Level Up Data
3
Topical vs Oral JAK Inhibitors for Vitiligo: How to Choose as Systemic Options Advance
4
Don't Be Rash: Balancing Topical Steroids in the Era of Nonsteroidals
5